ASUG Tech Connect brought AI adoption to a head. What do customers need to build with SAP AI? Is the Gen AI Hub for BTP ...

Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...